Skip to main content

Life expectancy at birth and at age 65 in England and Wales

Life expectancy at birth has been used as a measure of the health status of the population of England and Wales since the mid-nineteenth century. Recently published statistics from the UK Office for National Statistics show that the long-standing North-South divide in distribution of life expectancy across England continues, with people in the North of England generally living shorter lives than those living in the south.

Life Expectancy at Birth
Male life expectancy at birth was highest in East Dorset (82.9 years) and lowest in Blackpool (74.0 years). For females, life expectancy at birth was highest in Purbeck at 86.6 years and lowest in Manchester at 79.5 years. Life expectancy at birth increased across England and Wales by 1.3 years for males and 1.0 year for females between 2006–08 and 2010–12. This is part of a long-standing trend of improving life-expectancy, which is leading to a gradual increase in the average age of the population of England and Wales, and the elderly forming an increasing proportion of the population.

Life Expectancy at 65
Life expectancy at age 65 years of age was highest for men in Harrow, who were expected to live for an additional  20.9 years on average compared with 15.8 years for men in Manchester. For women at age 65, life expectancy was highest in Camden (23.8 years) and lowest in Blaenau Gwent (18.7 years). In 2010–12, approximately 28% of local areas in the East, 49% in the South East and 28% in the South West were in the 20% of areas with the highest male life expectancy at birth. In contrast, there was no local area in the North East and Wales in this group. A similar pattern was observed for females.

There are a number of explanations for the North-South divide in life expectancy, most importantly, socio-economic factors such as deprivation and lifestyle factors such as smoking and diet.

The figure to the top left shows life expectancy (LE) for males at birth by local authority district in England and Wales during the period 2010–12. This continuing divide in health status between the North and the South illustrates the need for a fairer funding formula for the NHS.

A shorter version of this blog post was published in the BMJ.

Comments

Post a Comment

Popular posts from this blog

MPH Student Presentations on the NHS Care.Data Programme

As part of a session on primary care data in the Health Informatics module on the Imperial Master of Public Health Programme, I asked students to work in two groups to present arguments for and against the NHS Care.Data programme. Care.Data is an NHS programme that will extract data from the medical records held by general practitioners (GPs) in England. The Care.Data programme takes advantage of the very high level of use of electronic medical records by GPs in England. After extraction, data will be uploaded to the NHS Health and Social Care Information Centre (HSCIC). The data will then be used for functions such as health care planning, monitoring disease patterns and research. The programme has been controversial with proponents arguing that the programme will bring many benefits for the NHS and the population of England; and opponents arguing it is a major breach of privacy. You can view the two presentations to help inform you further about these arguments: Arguments for th
6 comments
Read more

How can we work successfully across the health and care system to make a success of Pharmacy First?

Pharmacies in England to begin treating patients for seven common conditions. How can we work successfully across the health and care system to make a success of Pharmacy First? 1. The Pharmacy First scheme aims to provide convenient access to healthcare through community pharmacies. Patients with minor ailments or common conditions can seek advice and treatment directly from their local pharmacy instead of visiting a general practice, urgent care centre or emergency department. The conditions covered by the scheme may vary depending on local funding arrangements and participation of pharmacies.  2, A potential problem with Pharmacy First is pharmacists misdiagnosing a patient's condition. It may also lead to delays in patients seeing doctors when medical assessment is needed. To mitigate these risks, appropriate safeguards and referral pathways should be established, ensuring timely medical assessment when necessary. The scheme will also increase the workload of pharmacies, thereb
Post a Comment
Read more

Example ADHD Referral Letter

Dear Dr, I am writing to refer a 28-year-old male patient of mine, Mr [Patient's Name], for assessment for the diagnosis and treatment of Attention Deficit Hyperactivity Disorder (ADHD). After a thorough clinical assessment, I believe that Mr. [Patient's Name] meets the criteria for adult ADHD as outlined in NHS guidance for primary care teams in SE London. Mr [Patient's Name] has been under my care for XX years and, during this time, he reports several symptoms (greater than five symptoms in total) consistent with ADHD in adults that have been present for more than six months. These symptoms include difficulties in focusing, following through on tasks, hyperactivity, forgetfulness, impulsiveness, restlessness, and irritability. Mr [Patient's Name] also reports being easily distracted, struggling with time management, organisation, and completing tasks efficiently. Many of Mr [Patient's Name]'s symptoms have been present since he was under 12 years old; and have
Post a Comment
Read more